LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML
Product details
Registration number: SIN16295P
Classification: Prescription Only
Active ingredients: Inclisiran Sodium eqv Inclisiran
Strength: 284 mg
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: NOVARTIS (SINGAPORE) PTE LTD
ATC code: C10AX16
HSA approval date: 3 August 2021
Manufacturer(s):
- Corden Pharma S.p.A
- Novartis Pharmaceutical Manufacturing GmbH
Manufacturing country/countries: ITALY; AUSTRIA
What are the HSA registration number and classification for LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16295P
Classification: Prescription Only
What active ingredients and strength are recorded for LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Inclisiran Sodium eqv Inclisiran
Strength: 284 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Corden Pharma S.p.A
- Novartis Pharmaceutical Manufacturing GmbH
Manufacturing country/countries: ITALY; AUSTRIA
Where can I look up LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16295P or the exact product name LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML. The general register link does not preselect this product.
What are the source dates for this LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16295P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)